The CRISPR-Cas9 editing tool is combined with infrared light to enhance precision. Photo: iStock

Chinese scientists claim they have developed an infrared light-based, remotely-controlled gene-editing tool that can target and kill cancer cells with precision.

A team led by Professor Song Yujun from the Nanjing University’s College of Engineering and Applied Sciences designed an infrared light-responsive nano-carrier to be used for the CRISPR-Cas9 gene-editing tool, which will have great potential in cancer therapeutics.

The strong penetrability of infrared light enables scientists to precisely control the gene editing tool in deep human tissue.

The CRISPR-Cas9 technique allows genetic materials to be added, removed or altered in particular locations in the human genome. But it remains a challenge in precision medicine worldwide due to the off-target effect of the gene-editing tool, like causing mutation or even cancer in healthy cells due to the inaccurate excision of genes.

The new technique developed by Song’s team has been tested on lab rats with tumors, whose progression was delayed about 20 days after the rat was treated with the new technique.

“Using infrared light, the new technique can precisely alter or cut the designated spot in the genome, improving the target effect of the existing gene-editing tool,” Song told the People’s Daily.

But he said the new technique would still be far from human clinical trials due to concerns like the toxic effect of nano materials and that his team also needed to determine the amount of infrared light needed for curing cancers in humans. A thorough ethics review is also mandated by Chinese authorities.

Last year, Chinese biologist He Jiankui used the CRISPR-Cas9 tool and altered the CCR5 gene of human embryos in a morally deplorable experiment that led to the birth of the world’s first gene-edited babies.

China has tightened scrutiny of biomedical technology after the birth of the gene-edited twins shocked academia. The country updated a law on biomedical technology in February, which mandated high-risk clinical research projects including gene-editing must be approved by the National Health Commission, with both academic and ethics reviews as the prerequisite for clinical trials.

Join the Conversation

1091 Comments

  1. Hey There. I found your blog using msn. This is a very well written article. I’ll make sure to bookmark it and come back to read more of your useful info. Thanks for the post. I will certainly comeback.

  2. The very crux of your writing whilst sounding reasonable at first, did not work perfectly with me personally after some time. Somewhere throughout the paragraphs you were able to make me a believer but just for a short while. I however have a problem with your leaps in logic and one would do nicely to help fill in all those gaps. In the event that you actually can accomplish that, I could undoubtedly be impressed.

  3. I was very pleased to find this web-site.I wanted to thanks for your time for this wonderful read!! I definitely enjoying every little bit of it and I have you bookmarked to check out new stuff you blog post.

  4. I think this is one of the most important info for me. And i’m glad reading your article. But should remark on some general things, The web site style is perfect, the articles is really nice : D. Good job, cheers

  5. Hi! Would you mind if I share your blog with my twitter group? There’s a lot of folks that I think would really appreciate your content. Please let me know. Cheers

  6. Hi! This is my first visit to your blog! We are a group of volunteers and starting a new initiative in a community in the same niche. Your blog provided us valuable information to work on. You have done a marvellous job!